Developing first-in-class therapies to improve metabolic health.

ReRx: Rethinking Therapeutics and Pharmaceuticals
At ReRx we are developing novel oral therapeutics to treat patients with severe metabolic diseases including obesity, metabolic syndrome, diabetes, and liver diseases. Our therapeutics target metabolic pathways involved in regulating energy homeostasis and improve treatment outcomes compared to similar pharmacological agents.
Improving Treatment Outcomes with Innovative Solutions
The name ReRx draws inspiration from our commitment to (Re)-thinking therapeutics and pharmaceuticals (Rx) to develop new therapies and strategies that improve upon current treatment outcomes. Our mission is to revolutionize the field of metabolic disease treatments by targeting key metabolic pathways involved in regulating energy homeostasis.